CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 9,083 Value ($000) $0 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 11,025 Value ($000) $0 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 35,188 Value ($000) $1 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 29,455 Value ($000) $0 Avg Close $18.51 Range $15.23 - $21.65
Q1 2022
Shares 14,897 Value ($000) $327 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 12,335 Value ($000) $350 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 16,480 Value ($000) $347 Avg Close $20.92 Range $16.68 - $25.50